Correlation Between Ideaya Biosciences and Merus BV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ideaya Biosciences and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ideaya Biosciences and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ideaya Biosciences and Merus BV, you can compare the effects of market volatilities on Ideaya Biosciences and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ideaya Biosciences with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ideaya Biosciences and Merus BV.

Diversification Opportunities for Ideaya Biosciences and Merus BV

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Ideaya and Merus is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Ideaya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ideaya Biosciences are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Ideaya Biosciences i.e., Ideaya Biosciences and Merus BV go up and down completely randomly.

Pair Corralation between Ideaya Biosciences and Merus BV

Given the investment horizon of 90 days Ideaya Biosciences is expected to generate 2.28 times less return on investment than Merus BV. But when comparing it to its historical volatility, Ideaya Biosciences is 1.03 times less risky than Merus BV. It trades about 0.03 of its potential returns per unit of risk. Merus BV is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  2,028  in Merus BV on December 4, 2024 and sell it today you would earn a total of  2,519  from holding Merus BV or generate 124.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ideaya Biosciences  vs.  Merus BV

 Performance 
       Timeline  
Ideaya Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Ideaya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Merus BV 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Merus BV are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Merus BV is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Ideaya Biosciences and Merus BV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ideaya Biosciences and Merus BV

The main advantage of trading using opposite Ideaya Biosciences and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ideaya Biosciences position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.
The idea behind Ideaya Biosciences and Merus BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation